secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133298
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 2.04
LLM model:  deepseek-v4-flash:cloud@v2

Seres receives Oaktree default notice over $28M Bacthera payment; $110M term loan at risk
--------------------------------------------------------------------------------

- Received default notice from Oaktree alleging non-payment of ~$28M milestone to Bacthera; company disputes.
- $110M outstanding under $250M term loan; interest at SOFR+7.875% (floor 2.5%, cap 5%), maturity April 2029.
- Company believes no default occurred; intends to vigorously defend and pursue counterclaims if needed.
- If default stands, debt could be accelerated and default interest rate of 2% per annum would apply.
- Dispute hinges on whether Bacthera milestone is due and qualifies as 'Indebtedness' under credit agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524133298/0001193125-24-133298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524133298/d833710d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer